|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
1 event,
The Advances in Genome Biology and Technology (AGBT) General Meeting will be held Feb 27 – Mar 2, 2019 on Marco Island, Florida. AGBT provides a forum for exchanging information about the latest advances in DNA sequencing technologies, experimental and analytical approaches for genomic studies, and their myriad applications. Highlighted presentation topics include: Heterochromatin and |
0 events,
|
|||
|
1 event,
The 2019 Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 4 to March 7, 2019 in Seattle, Washington. This well-respected conference brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious |
0 events,
|
0 events,
|
0 events,
|
|||
|
0 events,
|
1 event,
The National Academies’ Nuclear and Radiation Studies Board (NRSB) will host “Challenges in Initiating and Conducting Long-Term Health Monitoring of Populations following Nuclear and Radiological Emergencies in the United States: A Workshop” on 12-13 March 2019 in Washington, D.C. Workshop participants will discuss the following topics: Environmental Consequences of Radioactive Material following a Nuclear or |
2 events,
The National Institute of Allergy and Infectious Diseases (NIAID) will host a Research Career "K" Development Workshop 13-14 March 2019 in Rockville, Maryland. The event is for currently active and new (typically those in year 1 or year 2 of their K award by the end of fiscal year 2018) awardees for the following K |
0 events,
|
0 events,
|
0 events,
|
|
|
1 event,
SMi Group’s Annual Superbugs & Superdrugs conference will take place 18-19 March, 2019 in London, UK. This year’s event will gather leaders from pharmaceutical companies, academia and the wider scientific community together with regulatory agencies and public-private partnerships, to discuss the growing threat of antibiotic resistance. Highlighted session topics and focus areas include: Development of |
1 event,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
